Enzo Buys VC-Backed Assay Designs
Enzo Biochem Inc. (NYSE: ENZ) has acquired the assets of Assay Designs Inc., an Ann Arbor, Mich.-based provider of immunoassay (ELISA) kits, luminescent reagents, antibodies and proteins for the life sciences research market. The deal was valued at approximately $12.2 million in cash. Assay Designs had raised around $5 million from Ampersand Ventures.
15 March 2009•3 mins read
